BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

544 related articles for article (PubMed ID: 22962314)

  • 1. Revisiting the classification of clinical phenotypes of anti-neutrophil cytoplasmic antibody-associated vasculitis: a cluster analysis.
    Mahr A; Katsahian S; Varet H; Guillevin L; Hagen EC; Höglund P; Merkel PA; Pagnoux C; Rasmussen N; Westman K; Jayne DR;
    Ann Rheum Dis; 2013 Jun; 72(6):1003-10. PubMed ID: 22962314
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antineutrophil cytoplasmic antibody-associated vasculitides: is it time to split up the group?
    Millet A; Pederzoli-Ribeil M; Guillevin L; Witko-Sarsat V; Mouthon L
    Ann Rheum Dis; 2013 Aug; 72(8):1273-9. PubMed ID: 23606701
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical impact of subgrouping ANCA-associated vasculitis according to antibody specificity beyond the clinicopathological classification.
    Deshayes S; Martin Silva N; Khoy K; Yameogo S; Mariotte D; Lobbedez T; Aouba A
    Rheumatology (Oxford); 2019 Oct; 58(10):1731-1739. PubMed ID: 30805643
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Brief Report: Circulating Cytokine Profiles and Antineutrophil Cytoplasmic Antibody Specificity in Patients With Antineutrophil Cytoplasmic Antibody-Associated Vasculitis.
    Berti A; Warner R; Johnson K; Cornec D; Schroeder D; Kabat B; Langford CA; Hoffman GS; Fervenza FC; Kallenberg CGM; Seo P; Spiera R; St Clair EW; Brunetta P; Stone JH; Merkel PA; Specks U; Monach PA;
    Arthritis Rheumatol; 2018 Jul; 70(7):1114-1121. PubMed ID: 29693324
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antineutrophil cytoplasmic antibody-associated vasculitis classification by cluster analysis based on clinical phenotypes: a single-center retrospective cohort study.
    Lee LE; Pyo JY; Ahn SS; Song JJ; Park YB; Lee SW
    Clin Rheumatol; 2024 Jan; 43(1):367-376. PubMed ID: 37530864
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The utility of the ACR/EULAR 2017 provisional classification criteria for granulomatosis with polyangiitis in Korean patients with antineutrophil cytoplasmic antibody-associated vasculitis.
    Yoo J; Kim HJ; Ahn SS; Jung SM; Song JJ; Park YB; Lee SW
    Clin Exp Rheumatol; 2018; 36 Suppl 111(2):85-87. PubMed ID: 29185957
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Myeloperoxidase-ANCA-positive granulomatosis with polyangiitis is a distinct subset of ANCA-associated vasculitis: A retrospective analysis of 455 patients from a single center in China.
    Chang DY; Li ZY; Chen M; Zhao MH
    Semin Arthritis Rheum; 2019 Feb; 48(4):701-706. PubMed ID: 29887327
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical outcomes of treatment of anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis based on ANCA type.
    Unizony S; Villarreal M; Miloslavsky EM; Lu N; Merkel PA; Spiera R; Seo P; Langford CA; Hoffman GS; Kallenberg CM; St Clair EW; Ikle D; Tchao NK; Ding L; Brunetta P; Choi HK; Monach PA; Fervenza F; Stone JH; Specks U;
    Ann Rheum Dis; 2016 Jun; 75(6):1166-9. PubMed ID: 26621483
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Epidemiology of Antineutrophil Cytoplasmic Autoantibody-Associated Vasculitis in Olmsted County, Minnesota: A Twenty-Year US Population-Based Study.
    Berti A; Cornec D; Crowson CS; Specks U; Matteson EL
    Arthritis Rheumatol; 2017 Dec; 69(12):2338-2350. PubMed ID: 28881446
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The complexity of classifying ANCA-associated small-vessel vasculitis in actual clinical practice: data from a multicenter retrospective survey.
    Corral-Gudino L; González-Vázquez E; Calero-Paniagua I; Pérez-Garrido L; Cusacovich I; Rivas-Lamazares A; Quesada-Moreno A; González-Fernández A; Mora-Peña D; Lerma-Márquez JL; Del-Pino-Montes J
    Rheumatol Int; 2020 Feb; 40(2):303-311. PubMed ID: 31385079
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Republished: Antineutrophil cytoplasmic antibody-associated vasculitides: is it time to split up the group?
    Millet A; Pederzoli-Ribeil M; Guillevin L; Witko-Sarsat V; Mouthon L
    Postgrad Med J; 2014 May; 90(1063):290-6. PubMed ID: 24737903
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Classification of antineutrophil cytoplasmic autoantibody vasculitides: the role of antineutrophil cytoplasmic autoantibody specificity for myeloperoxidase or proteinase 3 in disease recognition and prognosis.
    Lionaki S; Blyth ER; Hogan SL; Hu Y; Senior BA; Jennette CE; Nachman PH; Jennette JC; Falk RJ
    Arthritis Rheum; 2012 Oct; 64(10):3452-62. PubMed ID: 23023777
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical and prognostic features of Korean patients with MPO-ANCA, PR3-ANCA and ANCA-negative vasculitis.
    Yoo J; Kim HJ; Ahn SS; Jung SM; Song JJ; Park YB; Lee SW
    Clin Exp Rheumatol; 2017; 35 Suppl 103(1):111-118. PubMed ID: 28339364
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Anti-neutrophil cytoplasmic antibody-associated vasculitis. Clinical aspects and treatment].
    Paolini MV; Ruffino JP; Fernández Romero DS
    Medicina (B Aires); 2013; 73(2):119-26. PubMed ID: 23570759
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased sensitivity of the European medicines agency algorithm for classification of childhood granulomatosis with polyangiitis.
    Uribe AG; Huber AM; Kim S; O'Neil KM; Wahezi DM; Abramson L; Baszis K; Benseler SM; Bowyer SL; Campillo S; Chira P; Hersh AO; Higgins GC; Eberhard A; Ede K; Imundo LF; Jung L; Kingsbury DJ; Klein-Gitelman M; Lawson EF; Li SC; Lovell DJ; Mason T; McCurdy D; Muscal E; Nassi L; Rabinovich E; Reiff A; Rosenkranz M; Schikler KN; Singer NG; Spalding S; Stevens AM; Cabral DA;
    J Rheumatol; 2012 Aug; 39(8):1687-97. PubMed ID: 22589257
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protective Role of HLA-DRB1*13:02 against Microscopic Polyangiitis and MPO-ANCA-Positive Vasculitides in a Japanese Population: A Case-Control Study.
    Kawasaki A; Hasebe N; Hidaka M; Hirano F; Sada KE; Kobayashi S; Yamada H; Furukawa H; Yamagata K; Sumida T; Miyasaka N; Tohma S; Ozaki S; Matsuo S; Hashimoto H; Makino H; Arimura Y; Harigai M; Tsuchiya N
    PLoS One; 2016; 11(5):e0154393. PubMed ID: 27166610
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epidemiological features of Wegener's granulomatosis and microscopic polyangiitis: two diseases or one 'anti-neutrophil cytoplasm antibodies-associated vasculitis' entity?
    Mahr AD
    APMIS Suppl; 2009 Jun; (127):41-7. PubMed ID: 19515139
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Muscle biopsy in anti-neutrophil cytoplasmic antibody-associated vasculitis: diagnostic yield depends on anti-neutrophil cytoplasmic antibody type, sex and neutrophil count.
    Lacou M; Leroy M; Le Lan N; Toquet C; Espitia-Thibault A; Graveleau J; Masseau A; Agard C; Volteau C; Mussini JM; Hamidou M; Néel A
    Rheumatology (Oxford); 2021 Feb; 60(2):699-707. PubMed ID: 32789447
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antineutrophil cytoplasmic antibodies reacting with the pro form of proteinase 3 and disease activity in patients with Wegener's granulomatosis and microscopic polyangiitis.
    Russell KA; Fass DN; Specks U
    Arthritis Rheum; 2001 Feb; 44(2):463-8. PubMed ID: 11229478
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ANCA-Associated Vasculitis: Core Curriculum 2020.
    Geetha D; Jefferson JA
    Am J Kidney Dis; 2020 Jan; 75(1):124-137. PubMed ID: 31358311
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.